Robbins, Ivan M., MD

Robbins_Ivan_200x300.jpg
Rank:
Professor of Medicine
Director, Adult Pulmonary Hypertension Center
Director, Flolan Program
Primary Department:
Department of Medicine
Division:
Allergy, Pulmonary, and Critical Care Medicine
Office Address:
Vanderbilt University Medical Center
Division of Allergy, Pulmonary & Critical Care Medicine
1161 21st Ave. South, Suite T-1218 MCN
Nashville, TN 37232-2650
Office Phone:
615-322-3412
Phone to Schedule:
615-936-0393
Office Fax:
615-343-7448
Email:
ivan.robbins@vanderbilt.edu
Undergraduate School & Degree:
Brown University, B.A.
Medical School & Degree:
Case Western Reserve School of Medicine, M.D.

Brief Bio:

Dr. Robbins received his undergraduate degree from the Brown University in 1981 and his M.D. degree from Case Western Reserve School of Medicine in 1991. He trained in Internal Medicine at Metrohealth Medical Center from 1991-1994 and completed a Pulmonary and Critical Care Fellowship at Vanderbilt University from 1994-1997. Dr. Robbins attends a bi-weekly pulmonary hypertension outpatient clinic at The Vanderbilt Clinic. His research interests include the mechanism of action of epoprostenol and the role of oxidant stress and mitogenic factors in pulmonary arterial hypertension.
 

Expertise:

Invasive hemodynamic studies, cardiopulmonary exercise studies

Research Focus:

Pulmonary vascular diseases, clinical research, clinical trials

Publications:

Pugh, ME, Buchowski, MS, Robbins, IM, Newman, JH, Hemnes, AR. Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension. Chest, , , 2012.

Robbins, IM, Moore, TM, Blaisdell, CJ, Abman, SH. Improving outcomes for pulmonary vascular disease. Am J Respir Crit Care Med, 185(9), 1015-20, 2012.

Robbins, IM, Moore, TM, Blaisdell, CJ, Abman, SH. National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease. Circulation, 125(17), 2165-70, 2012.

Hemnes, AR, Pugh, ME, Newman, AL, Robbins, IM, Tolle, J, Austin, ED, Newman, JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest, 140(5), 1267-73, 2011.

Luo, YF, Robbins, IM, Karatas, M, Brixey, AG, Rice, TW, Light, RW. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chest, 140(1), 42-7, 2011. PMCID:3129440

Pugh, ME, Robbins, IM, Rice, TW, West, J, Newman, JH, Hemnes, AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant, 30(8), 904-11, 2011. PMCID:3129440

Robbins, IM, Hemnes, AR, Gibbs, JS, Christman, BW, Howard, L, Meehan, S, Cabrita, I, Gonzalez, R, Oyler, T, Zhao, L, Du, RH, Mendes, LA, Wilkins, MR. Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Exp Lung Res, 37(1), 26-34, 2011. PMCID:3129440

Austin, ED, Rock, MT, Mosse, CA, Vnencak-Jones, CL, Yoder, SM, Robbins, IM, Loyd, JE, Meyrick, BO. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Respir Med, 104(3), 454-62, 2010. PMCID:2826574

Austin, ED, Phillips, JA, Cogan, JD, Hamid, R, Yu, C, Stanton, KC, Phillips, CA, Wheeler, LA, Robbins, IM, Newman, JH, Loyd, JE. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir Res, 10, 87, 2009. PMCID:2762975

Hemnes, AR, Doyle, TP, Janssen, D, Robbins, IM. Congenital pulmonary artery stenoses masquerading as chronic thromboembolic disease. J Heart Lung Transplant, 28(10), 1110-1, 2009. PMCID:2757639

Hemnes, AR, Robbins, IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl, 15(1), 15-9, 2009. PMCID:2716716

Robbins, IM, Newman, JH, Johnson, RF, Hemnes, AR, Fremont, RD, Piana, RN, Zhao, DX, Byrne, DW. Association of the metabolic syndrome with pulmonary venous hypertension. Chest, 136(1), 31-6, 2009. PMCID:2716716

Tang, KJ, Robbins, IM, Light, RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Chest, 136(3), 688-93, 2009. PMCID:2757639

Johnson, RF, Loyd, JE, Mullican, AL, Fink, CA, Robbins, IM. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. J Heart Lung Transplant, 26(4), 363-9, 2007. PMCID:2716716

Cogan, JD, Pauciulo, MW, Batchman, AP, Prince, MA, Robbins, IM, Hedges, LK, Stanton, KC, Wheeler, LA, Phillips, JA, Loyd, JE, Nichols, WC. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am J Respir Crit Care Med, 174(5), 590-8, 2006. PMCID:2648061

Robbins, IM, Kawut, SM, Yung, D, Reilly, MP, Lloyd, W, Cunningham, G, Loscalzo, J, Kimmel, SE, Christman, BW, Barst, RJ. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur Respir J, 27(3), 578-84, 2006. PMCID:2648061

Willers, ED, Newman, JH, Loyd, JE, Robbins, IM, Wheeler, LA, Prince, MA, Stanton, KC, Cogan, JA, Runo, JR, Byrne, D, Humbert, M, Simonneau, G, Sztrymf, B, Morse, JA, Knowles, JA, Roberts, KE, McElroy, JJ, Barst, RJ, Phillips, JA. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 173(7), 798-802, 2006. PMCID:2662954

Cogan, JD, Vnencak-Jones, CL, Phillips, JA, Lane, KB, Wheeler, LA, Robbins, IM, Garrison, G, Hedges, LK, Loyd, JE. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med, 7(3), 169-74, 2005. PMCID:2662954

Robbins, IM, Morrow, JD, Christman, BW. Oxidant stress but not thromboxane decreases with epoprostenol therapy. Free Radic Biol Med, 38(5), 568-74, 2005. PMCID:2662954

Kuhn, KP, Wickersham, NE, Robbins, IM, Byrne, DW. Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol. Exp Lung Res, 30(2), 135-45, 2004. PMCID:2662954